Effectiveness and safety of dolutegravir two‐drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta‐analysis of real‐world evidenceYogesh Punekar, Annemiek de Ruiter, Shannon Ferrante et al.|HIV Medicine|2021Cited by 45
Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic ReviewVani Vannappagari, Michael Aboud, Leigh Ragone et al.|Antiviral Therapy|2018Cited by 18
Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir UseMelissa Crawford, Nassrin Payvandi, Jean van Wyk et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2019Cited by 12
Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studiesMounir Ait‐Khaled, Jean van Wyk, Juan Sierra Madero et al.|HIV Research & Clinical Practice|2021Cited by 11